Nasalcrom and Tinnitus aggravated - a phase IV clinical study of FDA data

Summary:

Tinnitus aggravated is reported as a side effect among people who take Nasalcrom (cromolyn sodium), especially for people who are female, 60+ old, also take Zyrtec, and have Asthma.

The phase IV clinical study analyzes which people have Tinnitus aggravated when taking Nasalcrom. It is created by eHealthMe based on reports of 1,489 people who have side effects when taking Nasalcrom from the FDA, and is updated regularly.

What is Nasalcrom?

Nasalcrom has active ingredients of cromolyn sodium. It is often used in allergies. eHealthMe is studying from 1,528 Nasalcrom users. Check the latest studies of Nasalcrom.

What is Tinnitus aggravated?

Tinnitus aggravated (ringing in the ears) is found to be associated with 1,551 drugs and 631 conditions by eHealthMe. Check the latest studies of Tinnitus aggravated.

On Jul, 29, 2026

1,489 people reported to have side effects when taking Nasalcrom.
Among them, 19 people (1.28%) have Tinnitus aggravated.

Could Nasalcrom cause Tinnitus aggravated?

Among these 19 people:

What is the gender of people who have Tinnitus aggravated when taking Nasalcrom? *

female: 94.74 %
male: 5.26 %

What is the age of people who have Tinnitus aggravated when taking Nasalcrom? *

What are other drugs people take besides Nasalcrom? *

What are other side effects people have besides Tinnitus aggravated? *

Cholestasis (a condition where bile cannot flow from the liver to the duodenum): 5 people, 26.32%
Fainting (loss of consciousness and postural tone): 5 people, 26.32%
Hepatic Failure (liver failure): 5 people, 26.32%
Retching (strong involuntary effort to vomit): 4 people, 21.05%
Dizziness: 4 people, 21.05%
Cushingoid (obesity and weakening of the muscles): 3 people, 15.79%
Eosinophil Count Increased: 3 people, 15.79%
Epstein-Barr Virus Antibody Positive: 3 people, 15.79%
Tremor (trembling or shaking movements in one or more parts of your body): 3 people, 15.79%
Asthma: 3 people, 15.79%

What are the existing conditions these people have? *

Asthma: 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Nasalcrom and have Tinnitus aggravated?

- Check whether Tinnitus aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nasalcrom:

Nasalcrom (1,528 reports)

Browse all side effects of Nasalcrom:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tinnitus aggravated:

Tinnitus aggravated (1,551 drugs)

Browse all the conditions that are associated with Tinnitus aggravated:

Tinnitus aggravated (631 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cromolyn sodium (the active ingredients of Nasalcrom) and Nasalcrom (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.